Documentation scienceplus.abes.fr version Bêta

À propos de : Clinical trial of mebendazole, a broad-spectrum anthelminthic.        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Clinical trial of mebendazole, a broad-spectrum anthelminthic.
has manifestation of work
related by
Abstract
  • Eighty-five children aged 5-14 years who were infested with worms were treated with mebendazole 100 mg twice daily for three days. The percentage cure rates were ascaris 100%, trichuris 94%, hookworm 82%, and hymenolepis 39%. The drug was well tolerated and with its broad activity should be very useful in treating those with multiple infestations.
article type
is part of this journal
PubMed ID
  • 1131521



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata